President Donald Trump, HHS Secretary Robert F. Kennedy, Jr., Dr. Oz, and others attend the “Making Health Technology Great Again” event, aiming to cut U.S. drug prices. Trump threatens drugmakers with action if they don’t comply with his goals to lower prices by Sept. 29, following an executive order in May.

Trump sends letters to 17 major pharmaceutical companies, urging them to cut U.S. drug prices and threatening consequences if they don’t comply. He revived a plan to tie U.S. drug prices to lower prices abroad. Drugmakers’ stocks drop following the announcement as Trump pushes for immediate relief for American families.

Trump asks drugmakers to provide existing medicines at the lowest price offered in other developed nations, negotiate for lower prices on new drugs, and sell directly to consumers. He demands an end to foreign countries benefiting from U.S. innovation and proposes tariffs on imported pharmaceuticals.

AstraZeneca proposes price cuts for some drugs in the U.S., following Trump’s push to lower drug prices. Companies like Eli Lilly and Novo Nordisk are considering selling drugs directly to patients. Drugmakers are preparing for potential tariffs on pharmaceuticals imported into the U.S.

Read more at CNBC: Trump asks drugmakers to cut U.S. prices within 60 days